Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study - Test2 - elhamkhani - TriplyDB

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study

http://www.wikidata.org/entity/Q28652626

about

Definitions of Metabolic Health and Risk of Future Type 2 Diabetes in BMI Categories: A Systematic Review and Network Meta-analysis Association between consumption of dairy products and incident type 2 diabetes--insights from the European Prospective Investigation into Cancer study Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabetics Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study The genetic architecture of type 2 diabetes Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association Putting the Genome in Context: Gene-Environment Interactions in Type 2 Diabetes.Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.Gene-lifestyle interaction and type 2 diabetes: the EPIC interact case-cohort study The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study.Interaction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into Cancer (EPIC)-InterAct.Diabetes incidence and projections from prevalence surveys in Samoa over 1978-2013.Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study.Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity.Risk of type 2 diabetes according to traditional and emerging anthropometric indices in Spain, a Mediterranean country with high prevalence of obesity: results from a large-scale prospective cohort study The association between dietary energy density and type 2 diabetes in Europe: results from the EPIC-InterAct Study Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study Gene × physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry.Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany study Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: the InterAct project Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population.Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.Residential neighbourhood greenspace is associated with reduced risk of incident diabetes in older people: a prospective cohort study Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis Validity of type 2 diabetes diagnosis in a population-based electronic health record database A method making fewer assumptions gave the most reliable estimates of exposure-outcome associations in stratified case-cohort studies Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study

P2860

Q26780349-592C32A0-F5F7-4C8F-961F-00A9FA511452 Q26801737-8F1C7A40-5CD8-47A2-872F-7FF5D81C2AB0 Q26863736-304771E7-F848-42C3-AFCF-6CEE581D589D Q28277713-354483C9-98C3-4CCB-AFB0-28299564343E Q28391913-8271FB29-AF29-4477-91DB-7724449D1C99 Q28648344-1F3DE40C-44BE-4E8E-8237-B072CF1AF099 Q28655857-8E5C8FC6-0E52-4ADF-A2C1-8C0823E659EF Q28729072-AD8162A0-26FE-41C8-A697-51A1268AB9E7 Q29583824-063366D1-00B5-43B6-B739-030B9317CCB7 Q30238784-08CB8853-A7CC-4568-98C9-81B07355AA80 Q30251394-AB92D5F5-D096-421B-9585-E9779AB55369 Q30316351-14F16718-6335-43DE-A2C8-591342F3C8EE Q30910636-B312097D-EBF2-4B7B-B138-81AB72A3C0E6 Q33638105-2DF0BA86-C215-4E8B-896F-CB7A0AE48E48 Q33687505-A29C06E7-A93D-4D6A-8D7E-CBC1A9F02550 Q33839290-8CBFAA96-0E47-4321-853A-E3E4D0728853 Q33844505-06CC779D-52D0-49B6-B982-A2EAFAEDA3A8 Q34289136-F5E27A96-24EE-4AB5-A5E4-57F9777CD6CD Q34297034-14D5F6C6-2B7D-4D98-8976-FC9805F12A51 Q34334832-E767E6F0-4E0D-44B0-8D88-BE7022F0229C Q34522356-B30B502A-F107-414A-AB79-A9307CC140C5 Q34559688-9EB4735F-F5F1-4BE3-AD96-49E9EEF9F61E Q34578758-A466B3B9-BE60-4D7A-B8CE-98E72D1D46BC Q34733641-DCBC5143-AD9F-4428-A2CA-09CD922DB2F0 Q34865971-4D8066CC-222E-40A8-8F86-5998EE4B2950 Q34916970-144B0278-2114-4DCC-8239-C15A051EDA0E Q34919132-9AF4C23B-AFBF-43C8-9F6B-7C5AE65D85FD Q35179825-852C6736-4E2E-4F3E-8CBA-68B288D91BF9 Q35230437-504E881E-C4EC-46C7-8349-58BB47CC3101 Q35757071-370AD1A6-C2A2-40CD-84B8-77C0B7AFBCF4 Q36013497-6D2C1897-B220-4354-A33E-F4F570CCF492 Q36043360-65A6B7DE-E16E-4D95-B4EA-2F945627B3BD Q36081622-2AD66F5C-E3A4-4A12-8567-9BEC5750D288 Q36198260-A6B7461A-4AF9-4E54-BD8D-F97E56C66674 Q36206751-F0B18ACF-584C-4D43-B207-27DA696683F8 Q36243079-B98FB108-BBD7-423A-933D-688B240B21C7 Q36287541-883101BA-A0B4-4E10-B010-F16C5DA38D8F Q36340891-89386A25-045B-40F5-9F77-4C4B69805396 Q36345777-F30C638D-AB14-4A9E-ABF4-60C309510191 Q36513866-929EE5C5-BA84-4FC8-86FE-16552525C2C7

P2860

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study

http://www.wikidata.org/entity/Q28652626

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Design and cohort description ...... e 2 diabetes in the EPIC Study

@ast

Design and cohort description ...... e 2 diabetes in the EPIC Study

@en

Design and cohort description ...... e 2 diabetes in the EPIC Study

@nl

type

label

Design and cohort description ...... e 2 diabetes in the EPIC Study

@ast

Design and cohort description ...... e 2 diabetes in the EPIC Study

@en

Design and cohort description ...... e 2 diabetes in the EPIC Study

@nl

prefLabel

Design and cohort description ...... e 2 diabetes in the EPIC Study

@ast

Design and cohort description ...... e 2 diabetes in the EPIC Study

@en

Design and cohort description ...... e 2 diabetes in the EPIC Study

@nl

P1433

Q28652626-C97E9B94-9067-4406-8A21-CB3FA1E23930

P1476

Q28652626-E03F7E11-1BB0-4426-B8A5-084B5FD80FF6

P2093

Q28652626-0B4B7286-5599-42DD-9E60-1325D4295646

Q28652626-1CC2AD77-FA2F-442E-9C18-41719299F7DB

Q28652626-20348A20-2064-447E-8434-27D1BAD9D55E

Q28652626-2077AAC2-FCC9-40E7-96A5-018E747A3500

Q28652626-2364B95F-4BFE-4FED-A0AD-405DC3B2F576

Q28652626-24ED81D8-CBEA-457A-8F53-9B4A22E97388

Q28652626-27B728FA-9085-45F9-B0AF-013C9C16D865

Q28652626-28262045-741A-4CDB-B66D-C7C990874B22

Q28652626-2F686781-E21F-413C-9EF5-EDF048FB9532

Q28652626-3218F560-F875-4BFB-AEFD-DC65B0641AF7

P2860

Q28652626-052FE82A-66F4-45CE-8540-ECAACA74E032

Q28652626-28CE5999-178A-4814-9619-68160B6C9CD8

Q28652626-41D98E1C-0B30-4B17-A1B1-86A8923F6D32

Q28652626-44DDF51A-8FAC-4BDF-B30D-4C2497BF1944

Q28652626-4D86324D-19CB-45AE-8484-2BEBD39D2B73

Q28652626-56274C96-A075-433E-9EB8-E42E1BE7003B

Q28652626-58307AC2-C3D3-4F58-9A30-5E1E31853A2A

Q28652626-5ABBCBFF-CB46-4345-BE87-2DA145340D4E

Q28652626-5AF7525A-CCA0-448F-AF37-E56DBB8A1EF1

Q28652626-5B80F69E-B1FD-4688-8726-814C9A83E92B

P2888

Q28652626-93D1373D-6337-4FDB-A084-9184F3D1DAC8

P304

Q28652626-45D29FAA-E496-4495-97E3-7A4087A5CDEF

P31

Q28652626-4A6FE5FA-D2F1-4D6A-8785-19BC729D78DC

P3181

Q28652626-9FF1A5AB-923F-4EA4-8220-885C52D2A8BA

P356

Q28652626-77587400-6248-4350-A6DD-4B8A68663FAD

P407

Q28652626-4DC6FC4A-0DE2-407B-8EF8-C01AC8EB134E

P433

Q28652626-F175ABF4-11C6-40B9-823B-6169CBA34618

P478

Q28652626-0716351C-A6D3-48C2-A01D-725BB2487A31

P50

Q28652626-0A0D64DE-8923-4D50-96FC-A300E5252509

Q28652626-0B08924D-BEA8-4B54-B08C-3D2A90F50DE2

Q28652626-12684506-21E8-4E1F-BB9B-13F0B304C06B

Q28652626-136FA5CD-7644-4276-9A08-7BD2EDB88EDA

Q28652626-2C1418EE-3265-4158-9E4A-2A5E58F7C0A8

Q28652626-2F4BE794-A6AF-44FE-BBCB-86A41782439A

Q28652626-333AE4C1-BFEC-4F53-B1AB-613970F1B1BC

Q28652626-4D3E57C2-57EB-4D5D-9D35-F3F36730F345

Q28652626-513E8EA7-579B-4F39-892E-0216AC85DC2C

Q28652626-5B8E6AF5-98EC-4306-97E0-9050EE782C31

P577

Q28652626-7A087B4F-3B46-42BA-825F-C52395736789

P5875

Q28652626-4D49C992-BEB8-4485-A242-BB8DB32DA6B5

P6179

Q28652626-9576B255-91CF-4975-B8F8-0AC6FABB5984

P698

Q28652626-FB6BBFE4-342E-4161-907C-FB7079233A03

P921

Q28652626-358B0225-193A-460A-888D-A74808FF5418

P932

Q28652626-1484573F-DB38-4C25-86E1-43E519C839AD

P3181

P356

S00125-011-2182-9

P1433

P1476

Design and cohort description ...... e 2 diabetes in the EPIC Study

@en

P2093

A M W Spijkerman

http://www.w3.org/2001/XMLSchema#string

A Ramachandran

http://www.w3.org/2001/XMLSchema#string

A Sandbaek

http://www.w3.org/2001/XMLSchema#string

B Balkau

http://www.w3.org/2001/XMLSchema#string

B Buijsse

http://www.w3.org/2001/XMLSchema#string

B Teucher

http://www.w3.org/2001/XMLSchema#string

B de Lauzon-Guillan

http://www.w3.org/2001/XMLSchema#string

C Gonzalez

http://www.w3.org/2001/XMLSchema#string

C Groves

http://www.w3.org/2001/XMLSchema#string

C Langenberg

http://www.w3.org/2001/XMLSchema#string

P2860

General and Abdominal Adiposity and Risk of Death in Europe

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

A genome-wide association study identifies novel risk loci for type 2 diabetes

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes

Genome-wide association studies in type 2 diabetes

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.

A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

Global estimates of the prevalence of diabetes for 2010 and 2030

P2888

s00125-011-2182-9

P304

2272-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4079119

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00125-011-2182-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Jaakko Tuomilehto

Salvatore Panico

Anne Tjønneland

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51455677

http://www.w3.org/2001/XMLSchema#string

P6179

1016705888

http://www.w3.org/2001/XMLSchema#string

P698

21717116

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4222062

http://www.w3.org/2001/XMLSchema#string